Baring Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.56M Sell
12,001
-2,801
-19% -$371K 0.09% 118
2017
Q2
$1.96M Sell
14,802
-797
-5% -$102K 0.13% 88
2017
Q1
$1.94M Sell
15,599
-6,161
-28% -$736K 0.14% 100
2016
Q4
$2.51M Buy
+21,760
New +$2.51M 0.17% 95
2016
Q3
Sell
-1,891
Closed -$229K 145
2016
Q2
$229K Sell
1,891
-2,469
-57% -$281K 0.02% 138
2016
Q1
$472K Buy
4,360
+229
+6% +$23.7K 0.04% 121
2015
Q4
$424K Hold
4,131
0.04% 121
2015
Q3
$386K Buy
+4,131
New +$400K 0.04% 129

Other funds holding JNJ

Baring Asset Management's JNJ Position: Q3 2017 in Review

Baring Asset Management reduced its Johnson & Johnson (JNJ) stake by 19% in Q3 2017, selling an estimated $371K and leaving 12,001 shares worth $1.56M. The position accounts for 0.09% of the portfolio, ranked #118.

Baring Asset Management first reported a position in JNJ in Q3 2015 and has held it in 8 quarters since. The position peaked at $2.51M in Q4 2016. 2,356 funds tracked by Wall St. Rank hold JNJ as of Q3 2017.

  • Baring Asset Management held 12,001 shares of Johnson & Johnson worth $1.56M as of Q3 2017.
  • Baring Asset Management sold 2,801 Johnson & Johnson shares in Q3 2017, an estimated $371K.
  • Johnson & Johnson made up 0.09% of Baring Asset Management's portfolio in Q3 2017, its #118 holding.
  • Baring Asset Management first reported a position in Johnson & Johnson in Q3 2015 and has held it in 8 quarters since.
  • Baring Asset Management's Johnson & Johnson position peaked at $2.51M in Q4 2016.
  • 2,356 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2017.

Based on Baring Asset Management's 13F filing for Q3 2017, filed 26 Oct 2017.